Robert J. Crowder

5.6k citations

27 papers · 2.1k indexed · 1 hit paper · h-index 18

Molecular Biology top 5%
Oncology top 5%
Cellular and Molecular Neuroscience top 5%
Cancer Research top 5%
Genetics top 5%

Co-authors: Robert S. Freeman Matthew J. Ellis Eugene M. Johnson Jeffrey Milbrandt Feng Gao X. Cynthia Lin Li Chanpheng Phommaly
Topics: PI3K/AKT/mTOR signaling in cancer (7 papers)Estrogen and related hormone effects (6 papers)Advanced Breast Cancer Therapies (5 papers)
Cited by: Developmental Neuroscience Cancer Research Cellular and Molecular Neuroscience
Journals: JAMA Journal of Biological Chemistry Journal of Clinical Oncology
Partner nations: United States Chile Canada

In The Last Decade

Robert J. Crowder

26 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phosphatidylinositol 3-Kinase and Akt Protein Kinase Are Necessary and Sufficient for the Survival of Nerve Growth Factor-Dependent Sympathetic Neurons

1998 501 citations Robert J. Crowder, Robert S. Freeman profile →

Peers

Countries citing papers authored by Robert J. Crowder

Since Specialization

Citations

This map shows the geographic impact of Robert J. Crowder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Crowder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Crowder more than expected).

Fields of papers citing papers by Robert J. Crowder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Crowder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Crowder. The network helps show where Robert J. Crowder may publish in the future.

Co-authorship network of co-authors of Robert J. Crowder

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Crowder. A scholar is included among the top collaborators of Robert J. Crowder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Crowder. Robert J. Crowder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-range function of secreted small nucleolar RNAs that direct 2′-O-methylation 2018 ·Journal of Biological Chemistry ·(unknown),Jiyeon Lee,Christopher L. Holley,Robert J. Crowder,Delphine L. Chen,Phyllis I. Hanson,Daniel S. Ory,Jean E. Schaffer	51
2	A Phase I Study of the AKT Inhibitor MK-2206 in Combination with Hormonal Therapy in Postmenopausal Women with Estrogen Receptor–Positive Metastatic Breast Cancer 2016 ·Clinical Cancer Research ·X. Cynthia,César Sánchez,Feng Gao,Robert J. Crowder,Michael Naughton,Timothy Pluard,(unknown),Zhanfang Guo,Jeremy Hoog,A. Craig Lockhart,Austin Doyle,Charles Erlichman,Matthew J. Ellis	62
3	Abstract 5544: Patient-derived xenograft study reveals the pharmacology and the role of ESR1 gene aberrations in endocrine therapy resistance of ER positive breast cancer 2014 ·Cancer Research ·Triparna Sen,Shunqiang Li,Jieya Shao,Robert J. Crowder,Robert T. Kitchens,Matthew J. Ellis	0
4	Importance of PI3-kinase pathway in response/resistance to aromatase inhibitors 2011 ·Steroids ·X. Cynthia,Robert J. Crowder,Matthew J. Ellis	36
5	Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer 2011 ·Breast Cancer Research ·César Sánchez,X. Cynthia,Robert J. Crowder,(unknown),Chanpheng Phommaly,Feng Gao,Lin Li,Matthew J. Ellis	148
6	Metastatic breast cancer detection and therapy monitoring using folate-targeting flow cytometry. 2011 ·Journal of Clinical Oncology ·Bo Hong,M L Mace,Robert J. Crowder,Timothy P. Coleman,(unknown),(unknown),John D. Feczko,(unknown)	2
7	PIK3CA and PIK3CB Inhibition Produce Synthetic Lethality when Combined with Estrogen Deprivation in Estrogen Receptor–Positive Breast Cancer 2009 ·Cancer Research ·Robert J. Crowder,Chanpheng Phommaly,Tao Yu,Jeremy Hoog,Jingqin Luo,Charles M. Perou,Joel S. Parker,Melinda A. Miller,David G. Huntsman,Lin Li,Jacqueline Snider,Sherri R. Davies,John A. Olson,Mark A. Watson,Anthony J. Saporita,Jason D. Weber,Matthew J. Ellis	174
8	Phosphatidyl-inositol-3-kinase alpha catalytic subunit mutation and response to neoadjuvant endocrine therapy for estrogen receptor positive breast cancer 2009 ·Breast Cancer Research and Treatment ·Matthew J. Ellis,Lin Li,Robert J. Crowder,Tao Yu,Jeremy Hoog,Jacqueline Snider,Sherri R. Davies,Katherine DeSchryver,Dean B. Evans,Jutta Steinseifer,Raj Bandaru,Weihua Liu,Humphrey Gardner,Semiglazov Vf,Mark A. Watson,Kelly K. Hunt,John A. Olson,José Baselga	110
9	Lower-Dose vs High-Dose Oral Estradiol Therapy of Hormone Receptor–Positive, Aromatase Inhibitor–Resistant Advanced Breast Cancer 2009 ·JAMA ·Matthew J. Ellis,Feng Gao,Farrokh Dehdashti,Donna B. Jeffe,P. Kelly Marcom,Lisa A. Carey,Maura N. Dickler,Paula Silverman,Gini F. Fleming,A. Kommareddy,(unknown),Robert J. Crowder,Barry A. Siegel	204
10	A randomized phase 2 trial of low dose (6 mg daily) versus high dose (30 mg daily) estradiol for patients with estrogen receptor positive aromatase inhibitor resistant advanced breast cancer. 2009 ·Cancer Research ·(unknown),(unknown),A. Kommareddy,(unknown),Robert J. Crowder,(unknown),Fei Gao,Gini F. Fleming,Paula Silverman,(unknown),LA Carey,P. Kelly Marcom	6
11	Dok-6, a Novel p62 Dok Family Member, Promotes Ret-mediated Neurite Outgrowth 2004 ·Journal of Biological Chemistry ·Robert J. Crowder,Hideki Enomoto,Mao Yang,Eugene M. Johnson,Jeffrey Milbrandt	89
12	NGF deprivation-induced gene expression: after ten years, where do we stand? 2004 ·Progress in brain research ·Robert S. Freeman,(unknown),Robert J. Crowder,(unknown),(unknown),(unknown),Liang Xie	82
13	Tyrosine 981, a Novel Ret Autophosphorylation Site, Binds c-Src to Mediate Neuronal Survival 2004 ·Journal of Biological Chemistry ·Mario Encinas,Robert J. Crowder,Jeffrey Milbrandt,Eugene M. Johnson	77
14	Cytosine arabinoside rapidly activates Bax-dependent apoptosis and a delayed Bax-independent death pathway in sympathetic neurons 2003 ·Cell Death and Differentiation ·Cagri G. Besirli,T L Deckwerth,Robert J. Crowder,Robert S. Freeman,Eugene M. Johnson	37
15	The Long and Short Isoforms of Ret Function as Independent Signaling Complexes 2002 ·Journal of Biological Chemistry ·(unknown),(unknown),Robert J. Crowder,Jeffrey Milbrandt,Eugene M. Johnson	93
16	Glycogen Synthase Kinase-3β Activity Is Critical for Neuronal Death Caused by Inhibiting Phosphatidylinositol 3-Kinase or Akt but Not for Death Caused by Nerve Growth Factor Withdrawal 2000 ·Journal of Biological Chemistry ·Robert J. Crowder,Robert S. Freeman	172
17	Expression of the SM‐20 Gene Promotes Death in Nerve Growth Factor‐Dependent Sympathetic Neurons 1999 ·Journal of Neurochemistry ·Elizabeth A. Lipscomb,Patrick D. Sarmiere,Robert J. Crowder,Robert S. Freeman	69
18	The Survival of Sympathetic Neurons Promoted by Potassium Depolarization, but Not by Cyclic AMP, Requires Phosphatidylinositol 3‐Kinase and Akt 1999 ·Journal of Neurochemistry ·Robert J. Crowder,Robert S. Freeman	50
19	The Survival of Sympathetic Neurons Promoted by Potassium Depolarization, but Not by Cyclic AMP, Requires Phosphatidylinositol 3-Kinase and Akt 1999 ·Journal of Neurochemistry ·Robert J. Crowder,Robert S. Freeman	34
20	Morphology of the male system and spermatophores of the arrowwormFerosagitta hispida(Chaetognatha) 1994 ·Journal of Morphology ·(unknown),Robert J. Crowder,George L. Shinn	5

About Robert J. Crowder

Robert J. Crowder is a scholar working on Cancer Research, Cellular and Molecular Neuroscience and Oncology, having authored 27 papers that have together received 2.1k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (7 papers), Estrogen and related hormone effects (6 papers) and Advanced Breast Cancer Therapies (5 papers). The work is most often cited by research in Developmental Neuroscience (154 citations), Cancer Research (425 citations) and Cellular and Molecular Neuroscience (446 citations). Robert J. Crowder has collaborated with scholars based in United States, Chile and Canada. Frequent co-authors include Robert S. Freeman, Matthew J. Ellis, Eugene M. Johnson, Jeffrey Milbrandt, Feng Gao, X. Cynthia, Lin Li, Chanpheng Phommaly, Jeremy Hoog and César Sánchez. Their work appears in journals such as JAMA, Journal of Biological Chemistry and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact